Skip to search formSkip to main contentSkip to account menu

L 693989

Known as: L-693,989, L-Proline, N2-(10,12-dimethyl-1-oxotetradecyl)-(4R,5R)-4,5-dihydroxy-L-ornithyl-L-threonyl-trans-4-hydroxy-L-prolyl-(S)-4-hydroxy-4-(4-(phosphonooxy)phenyl)-L-threonyl-threo-3-hydroxy-L-glutaminyl-3-hydroxy-, cyclic (6-1)-peptide, monosodium salt, 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Cyclic Peptides

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2015
Review
2015
Clinical Pharmacokinetics of Inhaled Antimicrobials
AbstractAdministration of inhaled antimicrobials affords the ability to achieve targeted drug delivery into the respiratory tract… 
Highly Cited
1995
Highly Cited
1995
Aerosol and parenteral pneumocandins are effective in a rat model of pulmonary aspergillosis
The pneumocandins are semisynthetic analogs of echinocandin-like compounds that have shown efficacy in animal models of systemic… 
1994
1994
Aerosolized L-693,989 for Pneumocystis carinii prophylaxis in rats
Water-soluble pneumocandin L-693,989, a potent antipneumocystis agent in the rat model for Pneumocystis carinii pneumonia (PCP… 
Highly Cited
1994
Highly Cited
1994
Morphological effects of lipopeptides against Aspergillus fumigatus correlate with activities against (1,3)-beta-D-glucan synthase
The lipopeptide antifungal agents, echinocandins, papulacandins, and pneumocandins, kill Candida albicans by inhibiting glucan… 
1992
1992
Antipneumocystis activity of water-soluble lipopeptide L-693,989 in rats
Water-soluble lipopeptide L-693,989 was evaluated for its antipneumocystis activity in rats. Rats from colonies with latent… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)